Compounds > farnesol

farnesol and Colonic Neoplasms

farnesol has been researched along with Colonic Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Dağ, İ; Feyzullazade, N; Şengel, T; Yilmaz Öztürk, B1
Au-Yeung, KK; Chan, C; Ko, JK; Lee, SS; Liu, PL; Wu, WY1
Biran, A; Brownstein, M; Haklai, R; Kloog, Y1
Newmark, HL; Rao, CV; Reddy, BS1
Halaschek-Wiener, J; Jansen, B; Kloog, Y; Schlagbauer-Wadl, H; Wacheck, V; Wolff, K1

Other Studies

5 other study(ies) available for farnesol and Colonic Neoplasms

ArticleYear
The investigation of in vitro effects of farnesol at different cancer cell lines.
    Microscopy research and technique, 2022, Volume: 85, Issue:8

    Topics: Adenocarcinoma; Apoptosis; Caco-2 Cells; Cell Proliferation; Colonic Neoplasms; Farnesol; Humans; Lung Neoplasms

2022
Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
    Cancer investigation, 2008, Volume: 26, Issue:7

    Topics: Anilides; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Caspase 3; Cell Proliferation; Cell Survival; Colonic Neoplasms; Diterpenes; Dose-Response Relationship, Drug; Enzyme Activation; Farnesol; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; PPAR gamma; Promoter Regions, Genetic; Survivin; Time Factors; Transcriptional Activation

2008
Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy.
    International journal of cancer, 2011, Feb-01, Volume: 128, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinases; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Down-Regulation; Farnesol; Flow Cytometry; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Microtubule-Associated Proteins; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Salicylates; Survivin; Valproic Acid

2011
Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis.
    Cancer detection and prevention, 2002, Volume: 26, Issue:6

    Topics: Animals; Azoxymethane; Cholesterol; Colonic Neoplasms; Farnesol; Lanosterol; Lipoproteins, HDL; Male; Precancerous Conditions; Rats; Rats, Inbred F344

2002
A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.
    Molecular medicine (Cambridge, Mass.), 2000, Volume: 6, Issue:8

    Topics: Blotting, Western; Cell Division; Cell Size; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Farnesol; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Mutation; Oligonucleotides, Antisense; Oncogene Protein p21(ras); Salicylates; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation

2000